Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Emmaus Life Sciences Inc (EMMA)

Emmaus Life Sciences Inc (EMMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Emmaus Life Sciences Inc 21250 HAWTHORNE BOULEVARD SUITE 800 TORRANCE CA 90503 USA

www.emmausmedical.com P: 310-214-0065

Description:

Emmaus Life Sciences Inc. is a commercial-stage biopharmaceutical company. It is engaged in the discovery, development, marketing and sale of treatments and therapies, for rare and orphan disease categories. Emmaus Life Sciences Inc., formerly known MYnd Analytics Inc., is based in Torrance, United States.

Key Statistics

Overview:

Market Capitalization, $K 2,555
Enterprise Value, $K 455
Shares Outstanding, K 63,866
Annual Sales, $ 29,600 K
Annual Net Income, $ -3,730 K
Last Quarter Sales, $ 5,380 K
Last Quarter Net Income, $ -2,180 K
EBIT, $ -780 K
EBITDA, $ 1,820 K
60-Month Beta 1.55
% of Insider Shareholders 35.00%
% of Institutional Shareholders 7.42%
Float, K 41,513
% Float 65.00%
Short Volume Ratio 0.55

Growth:

1-Year Return -87.69%
3-Year Return -98.97%
5-Year Return -99.54%
5-Year Revenue Growth 7,689.47%
5-Year Earnings Growth 99.37%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.03 on 09/10/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -0.09
EPS Growth vs. Prev Qtr 57.14%
EPS Growth vs. Prev Year 0.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-6 on 07/18/19

EMMA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -15.32%
Profit Margin % -12.60%
Debt/Equity -0.04
Price/Sales 0.08
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.89
Interest Coverage -0.49
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar